Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Epithelial Pleural Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04914897
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)

Who this might be right for
Pleural MesotheliomaNon-small Cell Lung Cancer
Sanofi 106
Early research (Phase 1)Active Not RecruitingNCT04897022
What this trial is testing

Pembrolizumab and Radiation Therapy in People With Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 7
Large-scale testing (Phase 3)Study completedNCT00651456
What this trial is testing

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study

Who this might be right for
Mesothelioma
Intergroupe Francophone de Cancerologie Thoracique 448
Testing effectiveness (Phase 2)Study completedNCT04480372
What this trial is testing

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Who this might be right for
Malignant Pleural MesotheliomaNon-small Cell Lung Cancer
Swiss Cancer Institute 68
Testing effectiveness (Phase 2)Study completedNCT02397928
What this trial is testing

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

Who this might be right for
Malignant Pleural Mesothelioma
NovoCure Ltd. 82
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Testing effectiveness (Phase 2)Study completedNCT00513877
What this trial is testing

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Cancer Trials Ireland 33
Early research (Phase 1)Study completedNCT00299962
What this trial is testing

Gene Therapy for Pleural Malignancies

Who this might be right for
Pleural MesotheliomaMetastatic Pleural Effusions
University of Pennsylvania 17
Testing effectiveness (Phase 2)Ended earlyNCT00281125
What this trial is testing

Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer and Pleural Mesothelioma
Nevada Cancer Institute 20
Not applicableWithdrawnNCT02106559
What this trial is testing

Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy

Who this might be right for
Stage III Malignant MesotheliomaStage IIIB Non-small Cell Lung CancerStage IV Malignant Mesothelioma+1 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00738582
What this trial is testing

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Morphotek 89
Testing effectiveness (Phase 2)Study completedNCT01721018
What this trial is testing

Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.

Who this might be right for
Malignant Pleural Mesothelioma
Virttu Biologics Limited 12
Testing effectiveness (Phase 2)Study completedNCT00386815
What this trial is testing

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Eli Lilly and Company 20
Testing effectiveness (Phase 2)UnknownNCT02436733
What this trial is testing

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

Who this might be right for
Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 64
Testing effectiveness (Phase 2)Study completedNCT00243074
What this trial is testing

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 54
Not applicableEnded earlyNCT04106973
What this trial is testing

Mesothelioma Early Detection by VOCs

Who this might be right for
Pleural MesotheliomaAsbestos ExposurePleural Plaque
Henry Ford Health System 12
Not applicableUnknownNCT01343264
What this trial is testing

Trimodality Therapy for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
HSK Wiesbaden 200
Testing effectiveness (Phase 2)Looking for participantsNCT07234058
What this trial is testing

Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 126
Large-scale testing (Phase 3)Study completedNCT00006231
What this trial is testing

Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaPerioperative/Postoperative Complications
University of Glasgow 44
Testing effectiveness (Phase 2)Study completedNCT05005429
What this trial is testing

Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma; Lung
Fundación GECP 47
Next Page